These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23666093)

  • 1. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
    Jost G; Pietsch H; Grenacher L
    Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
    Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
    Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-energy computed tomography for the assessment of early treatment effects of regorafenib in a preclinical tumor model: comparison with dynamic contrast-enhanced CT and conventional contrast-enhanced single-energy CT.
    Knobloch G; Jost G; Huppertz A; Hamm B; Pietsch H
    Eur Radiol; 2014 Aug; 24(8):1896-905. PubMed ID: 24871332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-molar gadobutrol as a contrast agent for computed tomography: results from a comparative porcine study.
    Kalinowski M; Kress O; Wels T; Alfke H; Klose KJ; Wagner HJ
    Invest Radiol; 2003 Apr; 38(4):193-9. PubMed ID: 12649642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation of contrast injection protocol to tube potential for cardiovascular CT.
    Wang Y; Bolen M; Sydow G; Kottha A; Soufan K; Bullen J; Kemper C; Kalafut J; Halliburton SS
    AJR Am J Roentgenol; 2014 Dec; 203(6):1181-91. PubMed ID: 25415695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracer kinetic model selection for dynamic contrast-enhanced computed tomography imaging of prostate cancer.
    Korporaal JG; van Vulpen M; van den Berg CA; van der Heide UA
    Invest Radiol; 2012 Jan; 47(1):41-8. PubMed ID: 21610505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Split-bolus spectral multidetector CT of the pancreas: assessment of radiation dose and tumor conspicuity.
    Brook OR; Gourtsoyianni S; Brook A; Siewert B; Kent T; Raptopoulos V
    Radiology; 2013 Oct; 269(1):139-48. PubMed ID: 23674791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of iodinated contrast agent properties on renal kinetics and oxygenation.
    Lenhard DC; Frisk AL; Lengsfeld P; Pietsch H; Jost G
    Invest Radiol; 2013 Apr; 48(4):175-82. PubMed ID: 23262792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
    Schnorr J; Wagner S; Ebert W; Heyer C; Laub G; Kivelitz D; Abramjuk C; Hamm B; Taupitz M
    Rofo; 2003 Jun; 175(6):822-9. PubMed ID: 12811696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized pharmacokinetic modeling for the detection of perfusion differences in skeletal muscle with DCE-MRI: effect of contrast agent size.
    Jaspers K; Leiner T; Dijkstra P; Oostendorp M; van Golde JM; Post MJ; Backes WH
    Med Phys; 2010 Nov; 37(11):5746-55. PubMed ID: 21158286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.
    Wang YC; Tang A; Chang D; Zhang SJ; Ju S
    Invest Radiol; 2014 Nov; 49(11):699-706. PubMed ID: 24879299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the zonal organization of tumor perfusion and permeability in a rat glioma model by using dynamic contrast-enhanced synchrotron radiation CT.
    Balvay D; Troprès I; Billet R; Joubert A; Péoc'h M; Cuenod CA; Le Duc G
    Radiology; 2009 Mar; 250(3):692-702. PubMed ID: 19095783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
    Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
    Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol.
    Pannu HK; Thompson RE; Phelps J; Magee CA; Fishman EK
    Acad Radiol; 2005 May; 12(5):576-84. PubMed ID: 15866130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the effectiveness of X-ray contrast media for abdominal computed tomographic examinations: comparison of four low-osmolality agents.
    Martí-Bonmatí L; Ronchera-Oms CL; Espinós MA; Jordán Y; Lucas A
    J Clin Pharm Ther; 1995 Apr; 20(2):75-81. PubMed ID: 7650078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast timing in computed tomography: effect of different contrast media concentrations on bolus geometry.
    Mahnken AH; Jost G; Seidensticker P; Kuhl C; Pietsch H
    Eur J Radiol; 2012 Apr; 81(4):e629-32. PubMed ID: 22297184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of upper limb position on the effect of a contrast agent in chest CT enhancement.
    Feng ST; Wang M; Gao Z; Tan G; Cai H; Hu X; Yang J; Li ZP
    Eur J Radiol; 2013 Jun; 82(6):1023-7. PubMed ID: 23357251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.